Vicore further strengthens patent protection for C21
Vicore further strengthens patent protection for C21 Stockholm, June 7, 2023 – Vicore Pharma Holding AB (STO: VICO) (“Vicore”) today announces that the European Patent Office (EPO) has granted Vicore’s patent protecting an improved C21 formulation based on enteric coated compositions. Th...
United States Carl Johan Dalsgaard Vicore Pharma Trademark Office European Patent Office Composition For Peroral Administration
Source: pharmiweb.com